Filippos Kontos
Overview
Explore the profile of Filippos Kontos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
344
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cattaneo G, Ventin M, Arya S, Kontos F, Michelakos T, Sekigami Y, et al.
Cancer Lett
. 2024 Feb;
587:216713.
PMID: 38364961
Human leukocyte antigen (HLA) class I defects are associated with cancer progression. However, their prognostic significance is controversial and may be modulated by immune checkpoints. Here, we investigated whether the...
2.
Neyaz A, Crotty R, Rickelt S, Pankaj A, Stojanova M, Michelakos T, et al.
Histopathology
. 2023 Jul;
83(4):546-558.
PMID: 37455385
Background: While many pancreatic neuroendocrine tumours (PanNET) show indolent behaviour, predicting the biological behaviour of small nonfunctional PanNETs remains a challenge. Nonfunctional PanNETs with an epigenome and transcriptome that resemble...
3.
Wei X, Michelakos T, He Q, Wang X, Chen Y, Kontos F, et al.
Oncologist
. 2023 May;
28(11):e1031-e1042.
PMID: 37159555
Aim: Tumor metabolism plays an important role in tumorigenesis and tumor progression. This study evaluated the potential association of tumor cell metabolism and immune cell tumor infiltration with the clinical...
4.
Michelakos T, Kontos F, Kurokawa T, Cai L, Sadagopan A, Krijgsman D, et al.
J Immunother Cancer
. 2022 Mar;
10(3).
PMID: 35277460
Purpose: The association of human leucocyte antigen (HLA) class I expression levels with the clinical course of many malignancies reflects their crucial role in the recognition and elimination of malignant...
5.
Lei X, Ou Z, Yang Z, Zhong J, Zhu Y, Tian J, et al.
Clin Cancer Res
. 2021 Apr;
27(13):3757-3771.
PMID: 33811153
Purpose: The limited efficacy of chimeric antigen receptor (CAR) T-cell therapies with solid malignancies prompted us to test whether epigenetic therapy could enhance the antitumor activity of B7-H3.CAR T cells...
6.
Michelakos T, Sekigami Y, Kontos F, Fernandez-Del Castillo C, Qadan M, Deshpande V, et al.
J Gastrointest Surg
. 2021 Jan;
25(11):2859-2870.
PMID: 33501584
Background: Dynamic survival data based on time already survived are lacking for resected borderline resectable/locally advanced (BR/LA) pancreatic ductal adenocarcinoma (PDAC) patients who received total neoadjuvant therapy (TNT) with FOLFIRINOX...
7.
Sekigami Y, Michelakos T, Fernandez-Del Castillo C, Kontos F, Qadan M, Wo J, et al.
Ann Surg Oncol
. 2021 Jan;
28(8):4592-4601.
PMID: 33393047
Background: Microscopically positive margins (R1) negatively impact survival in pancreatic ductal adenocarcinoma (PDAC). For patients with close/positive margins, intraoperative radiotherapy (IORT) can improve local control. The prognostic impact of an...
8.
Michelakos T, Kontos F, Barakat O, Maggs L, Schwab J, Ferrone C, et al.
Expert Opin Biol Ther
. 2020 Dec;
21(5):587-602.
PMID: 33301369
: Recent advances in immuno-oncology and bioengineering have rekindled the interest in monoclonal antibody (mAb)-based immunotherapies for malignancies. Crucial for their success is the identification of tumor antigens (TAs) that...
9.
Zhao L, Ye Y, Jiao J, Liao J, Lin Z, Zhong J, et al.
Oral Dis
. 2020 Nov;
27(7):1720-1727.
PMID: 33188651
Objective: Endoscopically assisted extracapsular dissection through a single incision along the cephaloauricular furrow has been adapted as a method of access for operating on benign parotid gland tumors. However, no...
10.
Kontos F, Michelakos T, Kurokawa T, Sadagopan A, Schwab J, Ferrone C, et al.
Clin Cancer Res
. 2020 Oct;
27(5):1227-1235.
PMID: 33051306
The recent impressive clinical responses to antibody-based immunotherapy have prompted the identification of clinically relevant tumor antigens that can serve as targets in solid tumors. Among them, B7-H3, a member...